Possible mechanisms involve elevating intracellular S100A9 via the TLR4/NF-κB pathway in both tumor cells and macrophages [65], as well as initiating the IL-6/p-STAT3/c-MYC pathway through the TLR4 receptor on macrophages [67]. Here, S100A9 is linked to neoplasm.